Skip to main content
Autobound logo

Edwards Lifesciences news and events in 2026

Edwards Lifesciences (NYSE: EW), is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees...

Public (EW)Medical Equipment Manufacturing10,000+ employeesedwards.comLinkedIn

Get Edwards Lifesciences' live signals in Claude or ChatGPT, or by API

Add to Claude / ChatGPT (MCP)Get an API key: 1,000 free credits
AskWhat changed at Edwards Lifesciences this week? Use Autobound signals for edwards.com.
Dated updates
65
Last event
Nov 1, 2026
Open rolesSnapshot Nov 3, 2026
80
Latest SEC filing
Aug 28, 2026

Source: Autobound Signal API · 65 signals tracked for Edwards Lifesciences · updated

Overview

Edwards Lifesciences by topic

Latest events

Latest Edwards Lifesciences events

All Edwards Lifesciences news →
  1. Office expansion
    Edwards Lifesciences opens new Sydney head office as heart valve disease burden growsEdwards Lifesciences has opened a new head office in Sydney.
    pharmadispatch.com
  2. Launch
    FDA Approves Transcatheter Tricuspid Valve Repair SystemEdwards Lifesciences received FDA approval for the PASCAL Ace with Capture Clarity system for use in degenerative mitral TEER procedures.
    dicardiology.com
  3. Launch
    FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve DiseaseEdwards Lifesciences received FDA approval making its PASCAL Precision system available for tricuspid valve repair in the US.
    bastillepost.com
  4. Earnings
    Edwards Lifesciences stock gets FDA approval for AUTUS valveEdwards Lifesciences reported adjusted earnings per share of USD 0.78 for the second quarter of 2026.
    ad-hoc-news.de
  5. Revenue
    Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart ValveEdwards Lifesciences reported Q2 revenue of $1.74 billion, exceeding Wall Street estimates.
    benzinga.com
  6. Investment
    Edwards Lifesciences' new plant in Moncada receives four million for training and renewable energyEdwards Lifesciences plans to invest over two million euros to install two photovoltaic plants for self-consumption at its Moncada facilities between 2026 and 2028.
    hortanoticias.com
  7. Launch
    Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valveEdwards Lifesciences has received FDA approval for its Autus valve, a first-of-its-kind size-adjustable pediatric heart valve designed to expand as a child grows.
    massdevice.com
  8. Facility expansion
    Edwards is already training fifty workers before the start of production at its new plant in 2027Edwards Lifesciences is in the final phase of constructing its sixth global heart valve factory in Moncada, Valencia, with operations set to begin in the first quarter of 2027.
    valenciaplaza.com

Signal API · MCP

Track Edwards Lifesciences with the Signal API

One POST /v1/companies/enrich call with edwards.com returns every signal type for Edwards Lifesciences, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"edwards.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Companies related to Edwards Lifesciences

Edwards Lifesciences questions

What is the latest news on Edwards Lifesciences?
On Nov 1, 2026, pharmadispatch.com reported: Edwards Lifesciences opens new Sydney head office as heart valve disease burden grows. This page tracks 8 news events for Edwards Lifesciences since Jul 27, 2026, each with a date and a source link.
What is going on with Edwards Lifesciences?
In the 90 days to Nov 4, 2026, Autobound tracked 7 news events, 1 8-K filing, 4 hiring snapshots, 32 signals for Edwards Lifesciences. The newest story is from Nov 1, 2026 (Office expansion), reported by pharmadispatch.com.
What else does Autobound track for Edwards Lifesciences?
Beyond news and filings, Autobound lists 50+ signals for Edwards Lifesciences from 5 sources: Glassdoor (15+), Website changes (15+), Patents (12), LinkedIn (7), Web traffic (1). See the Edwards Lifesciences signals page for the dated list.
Is Edwards Lifesciences hiring right now?
Yes. As of Nov 3, 2026, Edwards Lifesciences had 80 open roles, and Engineering had the most with 10.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →